AnalyzeDirect Francescutti V, Rivera L, Seshadri M, Kim M, Haslinger M, Camoriano M, Attwood K, Kane JM, 3rd, Skitzki JJ. The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis. Oncol Rep. July 2013;30(1):35-42.
Full Text – Open Access
Publication Date
July 2013
How Analyze was Used
“Post processing of datasets was performed using the medical imaging software, Analyze PC (Version 8.0; AnalyzeDirect, Overland Park, KS, USA).”
Keywords
Animals
Carcinoma/drug therapy/mortality
Cell Line, Tumor
Cell Survival/drug effects
Chemotherapy, Cancer, Regional Perfusion
Colorectal Neoplasms/drug therapy/mortality
Disease Models, Animal
Female
Hyperthermia, Induced
Infusions, Parenteral
Mice
Mice, Inbred BALB C
Mitomycin/administration & dosage/therapeutic use
Tumor Burden/drug effects
Author Affiliation(s)
Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, US.
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, US.
Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA,
Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 14263, US.
Note: specific affiliations were not provided by the publisher.
ID# 298
Tags: Animal Disease Models, Animals, Cancer_Chemotherapy_Regional Perfusion, Carcinoma/drug therapy/mortality, Cell Survival/drug effects, Colorectal Neoplasms/drug therapy/mortality, Female, Inbred BALB C Mice, Induced Hyperthermia, Mice, Mitomycin/administration & dosage/therapeutic use, Parenteral Infusions, Tumor Burden/drug effects, Tumor Cell Line